chr19-35282506-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The ENST00000598398.5(HAMP):c.-72C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,219,920 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00092 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 2 hom. )
Consequence
HAMP
ENST00000598398.5 5_prime_UTR
ENST00000598398.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.475
Genes affected
HAMP (HGNC:15598): (hepcidin antimicrobial peptide) The product encoded by this gene is involved in the maintenance of iron homeostasis, and it is necessary for the regulation of iron storage in macrophages, and for intestinal iron absorption. The preproprotein is post-translationally cleaved into mature peptides of 20, 22 and 25 amino acids, and these active peptides are rich in cysteines, which form intramolecular bonds that stabilize their beta-sheet structures. These peptides exhibit antimicrobial activity against bacteria and fungi. Mutations in this gene cause hemochromatosis type 2B, also known as juvenile hemochromatosis, a disease caused by severe iron overload that results in cardiomyopathy, cirrhosis, and endocrine failure. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HAMP | NM_021175.4 | upstream_gene_variant | ENST00000222304.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HAMP | ENST00000598398.5 | c.-72C>T | 5_prime_UTR_variant | 2/4 | 2 | P1 | |||
HAMP | ENST00000222304.5 | upstream_gene_variant | 1 | NM_021175.4 | P1 | ||||
HAMP | ENST00000593580.1 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.000933 AC: 142AN: 152232Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
142
AN:
152232
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00112 AC: 1200AN: 1067570Hom.: 2 Cov.: 16 AF XY: 0.00124 AC XY: 677AN XY: 548152
GnomAD4 exome
AF:
AC:
1200
AN:
1067570
Hom.:
Cov.:
16
AF XY:
AC XY:
677
AN XY:
548152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000919 AC: 140AN: 152350Hom.: 2 Cov.: 32 AF XY: 0.000966 AC XY: 72AN XY: 74502
GnomAD4 genome
AF:
AC:
140
AN:
152350
Hom.:
Cov.:
32
AF XY:
AC XY:
72
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hemochromatosis type 2B Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics, Synlab MVZ Humangenetik Freiburg | Mar 02, 2023 | The variant was detected heterozygously in a young patient with pronounced HFE hemochromatosis, who is also homozygous for the HFE variant c.845G>A, p.(Cys282Tyr). The HAMP variant c.-72C>T, p.?, has already been described as possibly pathogenic (Biasiotto et al. 2004, HGMD Professional 2022.4). Furthermore, other regulatory mutations have already been described as causative for juvenile hemochromatosis (including Island et al. 2009). It is listed with an allele frequency of 0.11% (35x heterozygous, 1x homozygous) in control databases (dbSNP rs367646034, gnomAD v2.1.1). Heterozygous pathogenic variants in the HAMP gene have been shown to increase the risk of iron overload in HFE c.845G>A heterozygotes and increase iron load in HFE c.845G>A homozygotes (Merryweather-Clarke et al 2003, Jacolot et al 2004; Piperno et al, geneReviews 2020). We evaluate the HAMP variant c.-72C>T, p.?, as a variant of unclear significance (VUS). - |
Hereditary hemochromatosis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 04, 2023 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 20
Find out detailed SpliceAI scores and Pangolin per-transcript scores at